Optiver Holding B.V. Esperion Therapeutics, Inc. Transaction History
Optiver Holding B.V.
- $3.63 Billion
- Q2 2025
A detailed history of Optiver Holding B.V. transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Optiver Holding B.V. holds 1,948 shares of ESPR stock, worth $5,532. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,948
Previous 5,929
67.14%
Holding current value
$5,532
Previous $8,000
87.5%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ESPR
# of Institutions
185Shares Held
109MCall Options Held
139KPut Options Held
604K-
Black Rock Inc. New York, NY14MShares$39.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$33.3 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT10.3MShares$29.4 Million0.05% of portfolio
-
Two Seas Capital LP Rye, NY9.95MShares$28.3 Million0.18% of portfolio
-
Pender Fund Capital Management Ltd. Vancouver, A16.68MShares$19 Million4.26% of portfolio
About Esperion Therapeutics, Inc.
- Ticker ESPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 66,551,600
- Market Cap $189M
- Description
- Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...